MA33516B1 - Nanoparticules métalliques, leur préparation et leurs utilisations - Google Patents
Nanoparticules métalliques, leur préparation et leurs utilisationsInfo
- Publication number
- MA33516B1 MA33516B1 MA34614A MA34614A MA33516B1 MA 33516 B1 MA33516 B1 MA 33516B1 MA 34614 A MA34614 A MA 34614A MA 34614 A MA34614 A MA 34614A MA 33516 B1 MA33516 B1 MA 33516B1
- Authority
- MA
- Morocco
- Prior art keywords
- nanoparticles
- relates
- preparation
- metal nanoparticles
- nanoparticle
- Prior art date
Links
- 239000002082 metal nanoparticle Substances 0.000 title abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 4
- 230000005865 ionizing radiation Effects 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne des nanoparticules activables pouvant être utilisées dans le secteur de la santé, en particulier de la santé humaine, pour perturber, modifier ou détruire des cellules, des tissus ou des organes cibles. Elle concerne plus particulièrement des nanoparticules pouvant générer un effet thérapeutique significativement efficace, lorsqu'elles sont exposées à des radiations ionisantes. La nanoparticule de l'invention est une nanoparticule métallique ayant, comme dimension la plus grande, une taille comprise entre environ 80 et 105 nm, le métal ayant de préférence un numéro atomique (Z) d'au moins 25. L'invention concerne également des compositions pharmaceutiques contenant une population de nanoparticules telles que définies précédemment, ainsi que leurs utilisations.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22457609P | 2009-07-10 | 2009-07-10 | |
| EP09165157A EP2275137A1 (fr) | 2009-07-10 | 2009-07-10 | Nanoparticules métalliques, leur préparation et utilisations |
| PCT/EP2010/059871 WO2011003999A1 (fr) | 2009-07-10 | 2010-07-09 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33516B1 true MA33516B1 (fr) | 2012-08-01 |
Family
ID=41110399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34614A MA33516B1 (fr) | 2009-07-10 | 2012-02-08 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9700621B2 (fr) |
| EP (3) | EP2275137A1 (fr) |
| JP (1) | JP5739883B2 (fr) |
| KR (1) | KR101670757B1 (fr) |
| CN (1) | CN102470173B (fr) |
| AU (1) | AU2010270225B2 (fr) |
| BR (2) | BR122019025997B8 (fr) |
| CA (1) | CA2765290C (fr) |
| CY (1) | CY1118600T1 (fr) |
| DK (2) | DK3178494T3 (fr) |
| EA (1) | EA020942B1 (fr) |
| ES (2) | ES2837412T3 (fr) |
| HR (2) | HRP20170175T1 (fr) |
| HU (2) | HUE031796T2 (fr) |
| IL (1) | IL217287A (fr) |
| LT (1) | LT2451481T (fr) |
| MA (1) | MA33516B1 (fr) |
| MX (2) | MX2012000285A (fr) |
| NZ (1) | NZ597564A (fr) |
| PL (2) | PL3178494T3 (fr) |
| PT (2) | PT3178494T (fr) |
| SG (2) | SG177611A1 (fr) |
| SI (1) | SI2451481T1 (fr) |
| SM (1) | SMT201700123T1 (fr) |
| WO (1) | WO2011003999A1 (fr) |
| ZA (1) | ZA201200902B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202108051XA (en) | 2009-07-08 | 2021-09-29 | Clene Nanomedicine Inc | Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor |
| EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
| US20120190979A1 (en) | 2011-01-24 | 2012-07-26 | Actium BioSystems, LLC | System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents |
| CA2846094C (fr) | 2011-08-26 | 2017-06-20 | Actium BioSystems, LLC | Appareil de generation de champ energetique pour traitement du cancer dans des cavites corporelles et des parties de type cavite |
| EA029635B1 (ru) * | 2011-12-16 | 2018-04-30 | Нанобиотикс | Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая |
| AR094577A1 (es) * | 2013-01-25 | 2015-08-12 | Nanobiotix | Composiciones para el tratamiento de cáncer, preparación y usos de las mismas |
| WO2014191569A1 (fr) * | 2013-05-30 | 2014-12-04 | Nanobiotix | Composition pharmaceutique, préparation et utilisations de celle-ci |
| EA201690050A1 (ru) * | 2013-06-20 | 2016-05-31 | Нанобиотикс | Композиции и способы для применения в медицинской диагностике |
| TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
| JP6778371B2 (ja) * | 2015-01-23 | 2020-11-04 | ミヨシ油脂株式会社 | 金微粒子マトリックスメタロプロテアーゼ阻害剤 |
| UA124572C2 (uk) | 2015-05-28 | 2021-10-13 | Нанобіотікс | Наночастинки для застосування як терапевтичної вакцини |
| DE102017101057A1 (de) * | 2017-01-20 | 2018-07-26 | Fraunhofer-Institut für Angewandte Polymerforschung IAP | Zwitterionische Nanopartikel |
| US11116793B2 (en) | 2017-11-13 | 2021-09-14 | National University Corporation Hokkaido University | Modified metal nanoparticle comprising cyclic polyether and pharmaceutical composition |
| CN110883341B (zh) * | 2018-09-11 | 2021-03-30 | 清华大学 | 金纳米团簇制备方法 |
| WO2021060498A1 (fr) * | 2019-09-27 | 2021-04-01 | 国立大学法人京都大学 | Nanoparticules contenant de la silice poreuse, leur procédé de production et composition pharmaceutique pour le traitement par rayonnement |
| KR20230038659A (ko) * | 2020-05-26 | 2023-03-21 | 나노비오띡스 | 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합 |
| JP2024511277A (ja) | 2021-02-19 | 2024-03-13 | メビオン・メディカル・システムズ・インコーポレーテッド | 粒子線治療システムのためのガントリー |
| EP4595983A1 (fr) | 2024-02-05 | 2025-08-06 | BXTA Nanotherapy Limited | Nanoparticules fonctionnalisées avec un agent stabilisant et un agent de ciblage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645464B1 (en) * | 1998-07-30 | 2003-11-11 | James F. Hainfeld | Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy |
| US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
| DE102007040934A1 (de) | 2007-08-30 | 2009-03-05 | Man Diesel A/S | Verfahren und Vorrichtung zur Reinigung von Abgas |
| EP2130553A1 (fr) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo |
| EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
-
2009
- 2009-07-10 EP EP09165157A patent/EP2275137A1/fr not_active Withdrawn
-
2010
- 2010-07-09 PT PT171525850T patent/PT3178494T/pt unknown
- 2010-07-09 NZ NZ597564A patent/NZ597564A/xx not_active IP Right Cessation
- 2010-07-09 PL PL17152585T patent/PL3178494T3/pl unknown
- 2010-07-09 KR KR1020127003701A patent/KR101670757B1/ko not_active Expired - Fee Related
- 2010-07-09 MX MX2012000285A patent/MX2012000285A/es active IP Right Grant
- 2010-07-09 ES ES17152585T patent/ES2837412T3/es active Active
- 2010-07-09 SG SG2012002044A patent/SG177611A1/en unknown
- 2010-07-09 BR BR122019025997A patent/BR122019025997B8/pt not_active IP Right Cessation
- 2010-07-09 ES ES10729917.4T patent/ES2616628T3/es active Active
- 2010-07-09 SG SG10201403832YA patent/SG10201403832YA/en unknown
- 2010-07-09 WO PCT/EP2010/059871 patent/WO2011003999A1/fr not_active Ceased
- 2010-07-09 MX MX2015010613A patent/MX347606B/es unknown
- 2010-07-09 AU AU2010270225A patent/AU2010270225B2/en not_active Ceased
- 2010-07-09 HU HUE10729917A patent/HUE031796T2/en unknown
- 2010-07-09 EP EP10729917.4A patent/EP2451481B1/fr active Active
- 2010-07-09 LT LTEP10729917.4T patent/LT2451481T/lt unknown
- 2010-07-09 PT PT107299174T patent/PT2451481T/pt unknown
- 2010-07-09 EP EP17152585.0A patent/EP3178494B1/fr active Active
- 2010-07-09 DK DK17152585.0T patent/DK3178494T3/da active
- 2010-07-09 CA CA2765290A patent/CA2765290C/fr active Active
- 2010-07-09 CN CN201080031148.1A patent/CN102470173B/zh active Active
- 2010-07-09 HU HUE17152585A patent/HUE052686T2/hu unknown
- 2010-07-09 DK DK10729917.4T patent/DK2451481T3/en active
- 2010-07-09 JP JP2012519006A patent/JP5739883B2/ja active Active
- 2010-07-09 SI SI201031410A patent/SI2451481T1/sl unknown
- 2010-07-09 BR BR112012000530A patent/BR112012000530B8/pt not_active IP Right Cessation
- 2010-07-09 EA EA201270154A patent/EA020942B1/ru not_active IP Right Cessation
- 2010-07-09 PL PL10729917T patent/PL2451481T3/pl unknown
- 2010-07-09 HR HRP20170175TT patent/HRP20170175T1/hr unknown
- 2010-07-09 SM SM20170123T patent/SMT201700123T1/it unknown
- 2010-07-09 US US13/383,049 patent/US9700621B2/en active Active
-
2011
- 2011-12-29 IL IL217287A patent/IL217287A/en active IP Right Grant
-
2012
- 2012-02-07 ZA ZA2012/00902A patent/ZA201200902B/en unknown
- 2012-02-08 MA MA34614A patent/MA33516B1/fr unknown
-
2017
- 2017-02-07 CY CY20171100166T patent/CY1118600T1/el unknown
- 2017-06-28 US US15/635,252 patent/US10391174B2/en active Active
-
2020
- 2020-12-15 HR HRP20202005TT patent/HRP20202005T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA33516B1 (fr) | Nanoparticules métalliques, leur préparation et leurs utilisations | |
| MA38318A1 (fr) | Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer | |
| Munawer et al. | Biofabrication of gold nanoparticles mediated by the endophytic Cladosporium species: Photodegradation, in vitro anticancer activity and in vivo antitumor studies | |
| MA32453B1 (fr) | Manoparticules inograniques, leur preparation et leurs utilisations | |
| Chouhan et al. | Arsenic and fluoride: two major ground water pollutants | |
| Barbasz et al. | Toxicity of silver nanoparticles towards tumoral human cell lines U-937 and HL-60 | |
| Jerobin et al. | Antibacterial activity of neem nanoemulsion and its toxicity assessment on human lymphocytes in vitro | |
| Vega-Jiménez et al. | Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications | |
| Castillo-Martínez et al. | Antibacterial and antibiofilm activities of the photothermal therapy using gold nanorods against seven different bacterial strains | |
| Avezov et al. | Oxidative stress in the oral cavity: sources and pathological outcomes | |
| Ribeiro et al. | Ceria nanoparticles decrease UVA-induced fibroblast death through cell redox regulation leading to cell survival, migration and proliferation | |
| ATE487470T1 (de) | Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse | |
| Shehata et al. | Zinc nanoparticles ameliorate the reproductive toxicity induced by silver nanoparticles in male rats | |
| Robles‐Martínez et al. | Antimycotic activity potentiation of Allium sativum extract and silver nanoparticles against Trichophyton rubrum | |
| Ritwik et al. | Peripheral odontogenic fibroma: a clinicopathologic study of 151 cases and review of the literature with special emphasis on recurrence | |
| NZ703047A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents | |
| Guo et al. | Polydopamine dual-modal nanotherapy synergizes photothermal antibacterial and nanozyme anti-inflammatory effects for periodontitis treatment | |
| Sharma et al. | Nanostrategies against rising antimicrobial resistance (AMR)-metallic nanoparticles as nanoweapon | |
| Shittu et al. | Polyethylene glycol–modified nanocarrier encapsulation of diminazene aceturate improved haematobiochemical recovery in trypanosoma brucei brucei infected rats | |
| Tatti | Nanoparticles production and inclusion in S. aureus incubated with polyurethane: An electron microscopy analysis | |
| Nemoda et al. | Comparative analysis of antibacterial and antibiofilm potential of chemically-and green laser-produced gold and silver nanoparticles against dental pathogens | |
| Xiao et al. | Tungsten disulfide atomic crystals with RONS scavenging and liver targeting capabilities for acetaminophen-induced acute liver injury therapy | |
| Rejeeth et al. | Biomimetic synthesis of noble metal Ag-NPs attenuates UVB-induced photodamage in HaCaT cells via antioxidant and anti-apoptotic mechanisms | |
| Ahamed et al. | Natural antioxidant curcumin attenuates NiO nanoparticle-induced cytotoxicity in mouse spermatogonia cells: A mechanistic study | |
| Adejuwon et al. | Radiation-induced testicular injury and its amelioration by Telfairia occidentalis |